From: How general practitioners would deprescribe in frail oldest-old with polypharmacy — the LESS study
Factors | Rated as very important or important, % |
---|---|
Risk of a medication | 99% |
Benefit of a medication | 98% |
Quality of life of the patient | 98% |
Life expectancy of the patient | 96% |
Potential negative health outcomes of medication’s change | 76% |
Interprofessional communication (between GPs and other prescribing physicians) | 73% |
Interprofessional collaboration (between GPs and other prescribing physicians) | 72% |
Age of the patient | 73% |
Existence of deprescribing guidelines | 64% |
Expectations of the patient | 63% |
Difficult communication (between GP and patient, e.g. due to cognitive impairment) | 56% |
Expectation of relatives | 49% |
Existence of tools that facilitate deprescribing | 48% |
Expenditure of time for thinking about and deprescribing in the older multimorbid patient with polypharmacy | 19% |
Self-dispensation of medication in GP office1 | 7% |